Volastra Therapeutics
About:
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Website: https://volastratx.com/
Top Investors: Eli Lilly, ARCH Venture Partners, Polaris Partners, Cornell University, Catalio Capital Management
Description:
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.
Total Funding Amount:
$119M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
New York, New York, United States
Founded Date:
2019-01-01
Founders:
Lewis Cantley, Olivier Elemento, Samuel Bakhoum
Number of Employees:
11-50
Last Funding Date:
2024-05-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai